TABLE 2

Comparison of oral BaP for 18 days: effects on body weight and spleen and thymus weights in Cyp1a1(−/−) versus Cyp1a1(+/+) mice

Values in all tables are expressed as means + S.E.M. Note that the same group of control animals was used for comparison with the three BaP doses. Both BaP-treated groups contained 12 mice; both control groups contained six mice. Any comparison with a P value > 0.05 is not denoted.

Cyp1a1(−/−) Cyp1a1(+/+)
BaP Control BaP Control
Oral BaP, 125 mg/kg/day
Body weight gain or loss (g) −5.2 ± 0.2 3.4 ± 0.5 2.4 ± 0.3 2.6 ± 0.4
P < 0.0001a,b,c
Spleen weight (mg/g body wt.) 0.5 ± 0.1 3.5 ± 0.1 2.6 ± 0.1 3.0 ± 0.2
P < 0.0001a,b,c P = 0.002b
Thymus weight (mg/g body wt.) 0.3 ± 0.0 3.3 ± 0.3 2.0 ± 0.2 2.8 ± 0.2
P < 0.0001a,b,c P = 0.026a
P = 0.007b
Oral BaP, 12.5 mg/kg/day
Body weight gain or loss (g) 0.7 ± 0.5 3.4 ± 0.5 2.6 ± 0.3 2.6 ± 0.4
P = 0.003a
P = 0.011b
P = 0.0026c
Spleen weight (mg/g body wt.) 2.4 ± 0.2 3.5 ± 0.1 2.6 ± 0.1 3.0 ± 0.3
P = 0.001a
Thymus weight (mg/g body wt.) 1.6 ± 0.3 3.3 ± 0.3 3.0 ± 0.4 2.8 ± 0.2
P = 0.012a
P = 0.034b
P = 0.02c
Oral BaP, 1.25 mg/kg/day
Body weight gain or loss (g) 1.2 ± 0.5 3.4 ± 0.5 2.7 ± 0.3 2.6 ± 0.4
P = 0.007a
P = 0.034b
P = 0.03c
Spleen weight (mg/g body wt.) 3.1 ± 0.2 3.5 ± 0.1 3.1 ± 0.1 3.0 ± 0.2
Thymus weight (mg/g body wt.) 2.9 ± 0.3 3.3 ± 0.3 2.8 ± 0.5 2.8 ± 0.2
  • a Comparison with control of same genotype.

  • b Comparison with control of other genotype.

  • c Comparison with other BaP-treated group.